ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Oklahoma » Interventional Cardiology

Top Interventional Cardiology Prescribers in Oklahoma

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MOHAMMAD GHANI M.D.

Interventional Cardiology

13,810

$849K

960
848 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 26%

$61
Average prescription price

Avg: $65

BRANISLAV SCHIFFERDECKER M.D.

Interventional Cardiology

13,388

$804K

1062
939 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 26%

$60
Average prescription price

Avg: $65

NAEEM TAHIRKHELI M.D.

Interventional Cardiology

13,287

$985K

829
667 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 26%

$74
Average prescription price

Avg: $65

DWAYNE SCHMIDT M.D.

Interventional Cardiology

12,985

$801K

1221
1127 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 26%

$62
Average prescription price

Avg: $65

IMRAN VIRK M.D.

Interventional Cardiology

11,223

$443K

668
481 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 26%

$39
Average prescription price

Avg: $65

MICHAEL PARTIN M.D.

Interventional Cardiology

10,669

$747K

982
823 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 26%

$70
Average prescription price

Avg: $65

JONATHAN VALUCK M.D.

Interventional Cardiology

10,237

$716K

754
660 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 26%

$70
Average prescription price

Avg: $65

CHRISTOPHER KERNS M.D.

Interventional Cardiology

8,689

$773K

724
671 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 26%

$89
Average prescription price

Avg: $65

THOMAS MCGARRY M.D.

Interventional Cardiology

8,577

$369K

687
617 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 26%

$43
Average prescription price

Avg: $65

TROY NORRED MD

Interventional Cardiology

6,792

$418K

525
410 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 26%

$62
Average prescription price

Avg: $65

MICHAEL SCHERLAG M.D.

Interventional Cardiology

6,474

$340K

801
709 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 26%

$53
Average prescription price

Avg: $65

KENNETH WONG M.D.

Interventional Cardiology

6,355

$429K

630
579 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 26%

$67
Average prescription price

Avg: $65

WAYNE LEIMBACH M.D.

Interventional Cardiology

5,716

$436K

656
564 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 26%

$76
Average prescription price

Avg: $65

BROOK SCOTT M.D.

Interventional Cardiology

5,714

$377K

540
491 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 26%

$66
Average prescription price

Avg: $65

MICHAEL SCHOEFFLER M.D.

Interventional Cardiology

4,949

$515K

577
504 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 26%

$104
Average prescription price

Avg: $65

MARC WEITZEL M.D.

Interventional Cardiology

4,364

$201K

390
293 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 26%

$46
Average prescription price

Avg: $65

AGHA KHAN M.D.

Interventional Cardiology

4,355

$214K

273
190 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 26%

$49
Average prescription price

Avg: $65

JOHN HARVEY MD

Interventional Cardiology

4,280

$238K

469
419 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 26%

$56
Average prescription price

Avg: $65

JOHN IVANOFF M.D.

Interventional Cardiology

3,848

$167K

411
341 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 26%

$43
Average prescription price

Avg: $65

GREGORY JOHNSEN MD

Interventional Cardiology

3,766

$227K

394
337 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 26%

$60
Average prescription price

Avg: $65

TERRIE GIBSON MD

Interventional Cardiology

3,712

$362K

438
359 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 26%

$98
Average prescription price

Avg: $65

FRANCIS OLIVER M.D.

Interventional Cardiology

3,473

$152K

328
292 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 26%

$44
Average prescription price

Avg: $65

KEITH KASSABIAN

Interventional Cardiology

3,216

$198K

339
274 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 26%

$62
Average prescription price

Avg: $65

MICHAEL CARNEY DO

Interventional Cardiology

2,902

$292K

310
250 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 26%

$100
Average prescription price

Avg: $65

ROBERT SMITH M.D.

Interventional Cardiology

2,783

$176K

327
266 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 26%

$63
Average prescription price

Avg: $65

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank